Amylyx Pharmaceuticals (AMLX) Files $300M Mixed Shelf
Tweet
Share
E-mail
Get Alerts AMLX Hot Sheet
Join SI Premium – FREE
Amylyx Pharmaceuticals (NASDAQ: AMLX) has filed $300,000,000 mixed shelf of:
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
UNITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Iran Will Pay For US Forces Killings Many Times Over
- Byrna Technologies names James White as SVP of retail & channel growth
- VivoPower names Syed Muhammad Nouman as group finance director
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
